To Top

Search By Topic

Acquisition

97 Articles available
Acquisition

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

PR-M04-18-NI-59
Acquisition

GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis

PAO-M04-18-NI-008
Acquisition

ImmunoPrecise Acquires ModiQuest Research BV

PR-M04-18-NI-37
Acquisition

Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio

PR-M04-18-NI-34
Acquisition

UCB Strengthens Research Capabilities With Acquisition of Element Genomics, a Duke University Biotech Spin-off

PR-M04-18-NI-32
Acquisition

Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and Commercialize Three NASH Assets from Lilly

PR-M04-18-NI-026
Acquisition

Inception Neuroscience Program Acquired by Roche

PR-M04-18-NI-023
Acquistion

HGS Acquires AxisPoint Health

PR-M04-18-NI-017
Acquistion

Avara Pharmaceutical Services Finalizes Acquisition of GSK Secondary Manufacturing and Packaging Facility in South Carolina

PR-M04-18-NI-015
Acquistion

FUJIFILM Expands into Bio-Medical Business with Acquisition

PR-M03-18-NI-103
Acquistion

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

PR-M03-18-NI-106
Acquistion

BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios 

PR-M03-18-NI-102
Acquisition

Citoxlab Acquires Solvo Biotechnology    

PAO-M03-18-NI-025
Acquistion

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

PR-M03-18-NI-087
Acquistion

Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

PR-M03-18-NI-071
Acquisition

Worldwide Clinical Trials Acquires Continuum Clinical’s Late Stage Research Practice

PR-M03-18-NI-065
Acquistion

Biogen to Acquire from Pfizer First-in-Class Phase 2b Ready Asset for Cognitive Impairment Associated with Schizophrenia

PR-M03-18-NI-049
Acquisition

Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy

PR-M03-18-NI-034
Acquistion

Boston Scientific Announces Acquisition of EMcision, Limited

PR-M03-18-NI-027
Acquistion

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

PR-M03-18-NI-019
Acquistion

Bruker Gains Access to QCL Technology with IRM2 Acquisition

PAO-M03-18-NI-004
Acquistion

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

PR-M03-18-NI-012
Acquisition

Roche Pays $1.9 Billion to Acquire Flatiron Health

PAO-M02-18-NI-021
Acquisition

Novacap acquires interest in Mailhot Industries

PR-M02-18-NI-80
Acquisition

Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.

PR-M02-18-NI-62
Acquistion

LANXESS successfully completes acquisition of Solvay’s phosphorus additive business

PR-M02-18-NI-051
Acquistion

Allergen Acquires Elastagen

PAO-M02-18-NI-012
Acquistion

Charles River Laboratories to Acquire MPI Research

PR-M02-18-NI-57
Acquistion

Celanese Completes Omni Acquisition

PAO-M02-18-NI-009
Acquistion

Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.

PR-M02-18-NI-026
Acquistion

Partner Therapeutics (PTx) Acquires Leukine® from Sanofi

PR-M02-18-NI-021
Acquisition

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

PR-M02-18-NI-001
Acquistion

Novacap TMT Enters into Definitive Agreement to Acquire Horizon Telcom

PR-M01-18-NI-096
Acquistion

Sanofi Will Acquire Ablynx for €3.9 Billion

PAO-M01-18-NI-045
Acqusition

Celgene Confirms $9 Billion Buyout of Juno Therapeutics

PAO-M01-18-NI-039
Acquisition

Sanofi Buys Bioverativ

PAO-M01-18-NI-036
Acquisition

Charles River Laboratories Continues to Grow Through Acquisition

PAO-M01-18-NI-035
Acquisition

Croda Buys Tech Companies in Canada, Finland

PR-M01-18-NI-048
Acquisition

Impact Biomedicines Acquired By Celgene

PAO-M01-18-NI-027
Acquistion

Takeda Moves into Stem-Cell Therapies with Acquisition of TiGenix

PAO-M01-18-NI-026
Acquistion

Charles River Laboratories Acquires KWS BioTest

PR-M01-18-NI-040
Immunology

Charles River Laboratories Gains Immunology Contract Research Services

PAO-M01-18-NI-023
Acquistion

Mallinckrodt Expands Rare Disease Pipeline with Sucampo Acquisition

PAO-M01-18-NI-017
Expansion

Recipharm Expands Stake in India

PAO-M01-18-NI-016
Strategic Partnership

Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma

PAO-M01-18-NI-002
Acquisition

Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs

PAO-M01-18-NI-001
PAO-M12-17-NI-001

Amerisource Bergen Expands in the US with Acquisition of H.D. Smith

PAO-M12-17-NI-001
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Acquisition

Almac Expands Analytical Services with BioClin Laboratories Acquisition

PAO-M11-17-NI-033
Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

PAO-M11-17-NI-020
CRO

CitoxLab acquires Xenometrics, an American CRO specialized in preclinical assessment of new drug candidates

PR-M10-17-NI-010
Acquistion

Novartis Plans Acquisition of Advanced Accelerator Applications for $3.9 Billion

PAO-M10-17-NI-045
Acquistion

Kite Pharma Acquisition by Gilead Finalized

PAO-M10-17-NI-017
Acquisition

Avara Acquires New OTC Solid Dose Capacity in South Carolina

PAO-M10-17-NI-001
Acquisition

Catalent Acquires Cook Pharmica

PAO-M09-17-NI-028
CDMO

Chinese Biopharmaceutical Company Acquires a Canada-Based CDMO

PAO-M09-17-NI-024
Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

PAP-Q3-17-NO-001
In Conversation

Mergers & Acquisitions: Combining Market Segments

PAP-Q3-17-IC-001
Global Partners

Building the Foundation of Japan’s Premier CDMO

PAP-Q3-17-CL-006
Expansion

Baxter Expands Generic Injectables Portfolio with Claris Injectables Acquisition

PAO-M09-17-NI-018
Pharma 2020

Russian Pharma Market Offers Great Potential for Local Manufacturers

PAP-Q3-17-CL-004
Acquisition

Carlyle Group, GTCR Complete AMRI Acquisition

PAO-M09-17-NI-013
Acquistion

Protein Sciences Officially Part of Sanofi

PAO-M09-17-NI-008
Acquisition

Aptuit Acquisition Completed by Evotec

PAO-M09-17-NI-001
Acquisition

Gilead Sciences to Fly Kite Pharma for $11.9 Billion

PAO-M08-17-NI-036
Acquisition

Perrigo Sells API Business to SK Capital

PAO-M08-17-NI-033
Acquisition

Mallinckrodt Acquires InfaCare Pharmaceutical Corporation for $425 Million

PAO-M08-17-NI-023
Acquistion

LabCorp Makes Another Acquisition

PAO-M08-17-NI-019
Acquisition

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy

PR-M08-17-NI-003
Acquistion

Brains On-Line Acquired by Charles River Laboratories for $21 million

PAO-M08-17-NI-017
Acquistion

Aptuit Acquisition Positions Evotec for Growth, Expansion

PAO-M08-17-NI-010
Acquisition

Horizon Discovery Acquires GE CRISPR Unit for $85 Million

PAO-M08-17-NI-002
Acquisition

Emergent BioSolutions Expands Its Drug Portfolio Through Two Acquisitions

PAO-M07-17-NI-030
Acquistion

Protein Sciences Snapped Up By Sanofi

PAO-M07-17-NI-024
Acquisition

Agilent Acquires Cobalt, a Raman Innovator

PAO-M07-17-NI-013
Acquisition

Ambry Genetics Acquired by Konica Minolta

PAO-M07-17-NI-012
Acquisition

Upsher-Smith Laboratories’ Generics Business Now Part of Sawai Pharmaceutical

PAO-M06-17-NI-016
CRO

CRO’s Move to Fill the Gap

PAO-M06-17-NI-006
Acquisition

AMRI Signs Acquisition Agreement

PAO-M06-17-NI-005
Acquisition

Bioverativ to Acquire True North

PAO-M05-17-NI-038
Acquisition

Astellas Completes Acquisition of Ogeda

PAO-M05-17-NI-026
Acquisition

Patheon Acquired by Thermo Fisher Scientific

PAO-M05-17-NI-016
Acquisition

Allergan Zeltiq Aesthetics Acquisition Finalized

PAO-M05-17-NI-010
Acquistion

Takeda Acquisition Followed by a Speedy Approval

PAO-M05-17-NI-001
Acquisition

Sawai Pharmaceutical Acquires Upsher‐Smith Generics Business

PAO-M04-17-NI-029
CDMO

Famar Expands Into North America

PAO-M04-17-NI-019
Logistics

Bain Capital, Cinven and STADA Make a Deal

PAO-M04-17-NI-016
CDMO

A Growing CDMO

Bill Pasek, Executive Vice President & Chief Commercial Officer, Avara Pharmaceutical Services

PTV-M01-17-NS-009
CDMO

Growing Through Consolidation

Derek Hennecke, Xcelience - a division of Capsugel, CEO and President

PTV-M11-16-AP-008
Supply Chain

An Inside Look: Strategy at SGS

Fadia Alkhalil-Gadar, VP of Global Business Development, SGS

PTV-M11-16-AP-020
CDMO

Sartorius Acquires Umetrics

PAO-M04-17-NI-010
CDMO

Avista Pharma Solutions Completes $4 Million Expansion

PAO-M04-17-NI-002
CDMO

Siegfried Sees Rise in Sales after Acquisitions

PAO-M03-17-NI-017
CDMO

Piramal Completes Acquisition of Drug Portfolio from Mallinckrodt

PAO-M03-17-NI-016
CDMO

Sustainable Strategies for Contract Development and Manufacturing Service Growth

PAP-Q03-16-NC-001
Acquisition

Mergers and Acquisitions: Protecting The Core and Maximizing Value

PAP-Q02-16-NC-001